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Memory CD8+ T cells (TMem) have the capacity to provide
lifelong host protection against intracellular pathogens and
cancer. Despite phenotypic and functional heterogeneity
among TMem, the expression of Fas — a tumor necrosis
family receptor (TNFR) superfamily member convention-
ally known as a death receptor — is held in common
among all TMem subsets across multiple species. As Fas
has been shown to mediate non-death signaling in other
cell types, we set out to elucidate the role of Fas signaling
in defined TMem subsets, including T stem cell memory
(TSCM), T central memory (TCM), and T effector memory
(TEM). We found that augmenting Fas signaling in stimu-
lated TSCM using an oligomerized form of its ligand FasL
resulted in augmented cellular differentiation and a loss in
IL-2 secretion capacity. Conversely, antibody blockade
(anti-FasL) of Fas signaling in TCM retarded cellular differ-
entiation both phenotypically and functionally. To geneti-
cally disentangle the pro-apoptotic and differentiation
signals from Fas, we made use of a mutant Fas lacking a
transmembrane cysteine residue (FasC194V) that is unable
to undergo S-palmitoylation and aggregate efficiently in
lipid rafts. Using transgenic mice expressing this C194V
Fas construct on a Fas-deficient lpr background, we found
that FasC194V TMem can still undergo cellular differentia-
tion in the absence of death signaling. In vivo, TMem
expanded with anti-FasL showed greater expansion, on-
target immunity and withheld differentiation. Additionally,
in a relevant syngeneic model of current human T cell
immunotherapy, TMem cells expanded with anti-FasL and
genetically engineered with an anti-CD19 chimeric antigen
receptor (CAR) exhibited enhanced CAR expression,
reduced differentiation, and augmented anti-lymphoma
activity compared to controls. These studies demonstrate
that Fas signaling promotes not only cell death but also
TMem effector differentiation, a finding that has implica-
tions for the design and execution of T cell-based immu-
notherapies in patients with cancer or infectious disease.
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